3nw9
From Proteopedia
(Difference between revisions)
(8 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | [[Image:3nw9.jpg|left|200px]] | ||
- | + | ==Rat COMT in complex with a methylpurin-containing bisubstrate inhibitor== | |
- | + | <StructureSection load='3nw9' size='340' side='right'caption='[[3nw9]], [[Resolution|resolution]] 1.65Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[3nw9]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3NW9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3NW9 FirstGlance]. <br> | |
- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.65Å</td></tr> | |
- | --> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=637:N-[(E)-3-[(2R,3S,4R,5R)-3,4-DIHYDROXY-5-(6-METHYLPURIN-9-YL)OXOLAN-2-YL]PROP-2-ENYL]-5-(4-FLUOROPHENYL)-2,3-DIHYDROXY-BENZAMIDE'>637</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=NHE:2-[N-CYCLOHEXYLAMINO]ETHANE+SULFONIC+ACID'>NHE</scene></td></tr> |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3nw9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3nw9 OCA], [https://pdbe.org/3nw9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3nw9 RCSB], [https://www.ebi.ac.uk/pdbsum/3nw9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3nw9 ProSAT]</span></td></tr> | |
+ | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/COMT_RAT COMT_RAT] Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. Also shortens the biological half-lives of certain neuroactive drugs, like L-DOPA, alpha-methyl DOPA and isoproterenol. | ||
- | == | + | ==See Also== |
- | + | *[[Catechol O-methyltransferase 3D structures|Catechol O-methyltransferase 3D structures]] | |
- | + | __TOC__ | |
- | + | </StructureSection> | |
- | [[ | + | [[Category: Large Structures]] |
- | [[Category: | + | |
[[Category: Rattus norvegicus]] | [[Category: Rattus norvegicus]] | ||
- | [[Category: Rudolph | + | [[Category: Benz J]] |
+ | [[Category: Ehler A]] | ||
+ | [[Category: Rudolph MG]] | ||
+ | [[Category: Schlatter D]] | ||
+ | [[Category: Stihle M]] |
Current revision
Rat COMT in complex with a methylpurin-containing bisubstrate inhibitor
|